PML body meets telomere: the beginning of an ALTernate ending?

Nucleus
Inn ChungKarsten Rippe

Abstract

The unlimited proliferation potential of cancer cells requires the maintenance of their telomeres. This is frequently accomplished by reactivation of telomerase. However, in a significant fraction of tumors an alternative lengthening of telomeres (ALT) mechanism is active. The molecular mechanism of the ALT pathway remains elusive. In particular, the role of characteristic complexes of promyelocytic leukemia nuclear bodies (PML-NBs) with telomeres, the ALT-associated PML-NBs (APBs), is currently under investigation. Here, we review recent findings on the assembly, structure and functions of APBs. It is discussed how genomic aberrations in ALT-positive cancer cells could result in the formation of APBs and in ALT activity. We conclude that they are important functional intermediates in what is considered the canonical ALT pathway and discuss deregulations of cellular pathways that contribute to the emergence of the ALT phenotype.

References

May 31, 1990·Nature·C B HarleyC W Greider
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·K R Prowse, C W Greider
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W Shay, S Bacchetti
Jul 2, 1998·Biochemical and Biophysical Research Communications·Y TokutakeY Furuichi
Jul 24, 1998·Biochemical and Biophysical Research Communications·H OginoD Ayusawa
Aug 8, 1998·Trends in Cell Biology·A S Belmont, A F Straight
May 25, 1999·Cell·J D GriffithT de Lange
Dec 22, 1999·Histochemistry and Cell Biology·C A May
Jan 29, 2000·The Journal of Cell Biology·F M BoisvertD P Bazett-Jones
Feb 29, 2000·The Journal of Biological Chemistry·H Saitoh, J Hinchey
Dec 2, 2000·Nature Genetics·M A DunhamR R Reddel
Sep 14, 2001·Human Molecular Genetics·M A CeroneS Bacchetti
Dec 26, 2001·Nature Cell Biology·Masafumi MurataniDavid L Spector
Feb 19, 2002·Oncogene·Jeremy D HensonRoger R Reddel
Nov 22, 2002·Human Molecular Genetics·Dimitrios J StavropoulosM Stephen Meyn
Sep 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yutong XueWeidong Wang
Dec 1, 1961·Experimental Cell Research·L HAYFLICK, P S MOORHEAD
Nov 11, 2003·Nature·Fabrizio d'Adda di FagagnaStephen P Jackson
Dec 6, 2003·The EMBO Journal·Chris MolenaarRoeland W Dirks
Apr 3, 2004·Cancer Research·J Arturo Londoño-VallejoRoger R Reddel
Jun 17, 2004·Molecular and Cellular Biology·Zaineb R Abdul RazakDominique Broccoli
Aug 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sabine M GörischPeter Lichter
Oct 1, 2004·Molecular Biology of the Cell·Ferhan Ayaydin, Mary Dasso
Oct 29, 2004·Molecular and Cellular Biology·Anthony J Cesare, Jack D Griffith

❮ Previous
Next ❯

Citations

Nov 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Lisa A PooleDavid Cortez
Feb 25, 2014·Protein & Cell·Yan HuangZhou Songyang
Feb 26, 2013·The EMBO Journal·Inn Chung, Xiaolan Zhao
Dec 9, 2014·Nucleus·Umut SahinValérie Lallemand-Breitenbach
Oct 10, 2015·Adipocyte·Judith ToneattoGraciela Piwien-Pilipuk
Jun 11, 2015·Molecular Neurodegeneration·Sara Anjomani VirmouniMark A Pook
Apr 8, 2014·Current Opinion in Cell Biology·Judith E Sleeman, Laura Trinkle-Mulcahy
Jun 9, 2016·Current Opinion in Genetics & Development·Alkmini Kalousi, Evi Soutoglou
Oct 19, 2016·Methods : a Companion to Methods in Enzymology·Manuel GunkelKarsten Rippe
Oct 21, 2016·Antioxidants & Redox Signaling·Sarah TessierValérie Lallemand-Breitenbach
Sep 25, 2019·PloS One·Javier Rodriguez-CentenoLeandro Sastre
Apr 23, 2020·International Journal of Molecular Sciences·Kristine SalminaJekaterina Erenpreisa
Feb 19, 2019·Oncotarget·Dalal Bakhos-DouaihyFrançois D Boussin
May 20, 2018·BMC Genetics·Delia M BraunKarsten Rippe
Jan 13, 2018·Nature Communications·Priya ChudasamaStefan Fröhling
Jan 3, 2019·Current Genetics·Martina Oravcová, Michael N Boddy
Oct 18, 2020·Nucleic Acids Research·Armelle CorpetPatrick Lomonte
Mar 7, 2021·International Journal of Molecular Sciences·Elisa MentegariGiovanni Maga
Apr 10, 2018·Biophysical Journal·Fabian Erdel, Karsten Rippe
Apr 27, 2021·Frontiers in Genetics·Lilit NersisyanArsen Arakelyan
May 15, 2021·Current Osteoporosis Reports·Navnit S Makaram, Stuart H Ralston
Jun 3, 2021·International Journal of Molecular Sciences·Ya-Chu ChangAnja-Katrin Bielinsky
Jun 3, 2021·International Journal of Molecular Sciences·Alexander V FoninKonstantin K Turoverov
Jul 23, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Semen V NesterovVladimir N Uversky

❮ Previous
Next ❯

Methods Mentioned

BETA
sumoylation

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.